196 related articles for article (PubMed ID: 31190827)
21. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents.
Johnson M; Månsson JE; Ostlund S; Fransson G; Areskoug B; Hjalmarsson K; Landgren M; Kadesjö B; Gillberg C
Atten Defic Hyperact Disord; 2012 Dec; 4(4):199-204. PubMed ID: 22753087
[TBL] [Abstract][Full Text] [Related]
22. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder.
Hariri M; Djazayery A; Djalali M; Saedisomeolia A; Rahimi A; Abdolahian E
Malays J Nutr; 2012 Dec; 18(3):329-35. PubMed ID: 24568073
[TBL] [Abstract][Full Text] [Related]
23. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents.
Chang JP; Su KP
Clin Psychopharmacol Neurosci; 2020 Nov; 18(4):469-483. PubMed ID: 33124582
[TBL] [Abstract][Full Text] [Related]
24. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels.
Chang JP; Su KP; Mondelli V; Satyanarayanan SK; Yang HT; Chiang YJ; Chen HT; Pariante CM
Transl Psychiatry; 2019 Nov; 9(1):303. PubMed ID: 31745072
[TBL] [Abstract][Full Text] [Related]
25. Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients.
Yonezawa K; Nonaka S; Iwakura Y; Kusano Y; Funamoto Y; Kanchi N; Yamaguchi N; Kusumoto Y; Imamura A; Ozawa H
J Neural Transm (Vienna); 2018 Sep; 125(9):1395-1400. PubMed ID: 29926268
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.
Chang JP; Su KP; Mondelli V; Pariante CM
Neuropsychopharmacology; 2018 Feb; 43(3):534-545. PubMed ID: 28741625
[TBL] [Abstract][Full Text] [Related]
27. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
28. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
[TBL] [Abstract][Full Text] [Related]
29. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
30. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
[TBL] [Abstract][Full Text] [Related]
31. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.
Bloch MH; Qawasmi A
J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):991-1000. PubMed ID: 21961774
[TBL] [Abstract][Full Text] [Related]
33. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
34. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
35. The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder - a review.
Martins BP; Bandarra NM; Figueiredo-Braga M
Crit Rev Food Sci Nutr; 2020; 60(9):1431-1446. PubMed ID: 30880398
[TBL] [Abstract][Full Text] [Related]
36. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
37. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
38. Personalised medicine in child and Adolescent Psychiatry: Focus on omega-3 polyunsaturated fatty acids and ADHD.
Pei-Chen Chang J
Brain Behav Immun Health; 2021 Oct; 16():100310. PubMed ID: 34589802
[TBL] [Abstract][Full Text] [Related]
39. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
[TBL] [Abstract][Full Text] [Related]
40. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
